David Ausländer, PhDAssociate Director at Novartis Pharma AGSpeaker
Profile
David Ausländer completed his PhD in 2014 at ETH Zürich in Switzerland, where he studied Mammalian Synthetic Biology. He joined Novartis in 2017, where he leads a global team in the Biologics Research Center focusing on Manufacturing Cell Line Development. His group develops and applies innovative gene- and cell line engineering solutions to enhance quality and productivity of manufacturing cell lines producing New Biologics Entities and Viral Vectors for Cell and Gene Therapies.
Agenda Sessions
Tailor-made CHO manufacturing cell lines using artificial intronic miRNAs
, 14:10View Session